Silvercrest Asset Management
WGS icon

Silvercrest Asset Management’s GeneDx Holdings WGS Stock Holding History

Silvercrest Asset Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-76,383
Closed -$4.91M – 886
2026
Q1 		$4.91M Buy
76,383
+14,472
+23% +$1.32M 0.04% 430
2025
Q4 		$8.05M Buy
61,911
+121
+0.2% +$16.6K 0.06% 363
2025
Q3 		$6.66M Sell
61,790
-31,587
-34% -$3.44M 0.04% 385
2025
Q2 		$8.62M Buy
93,377
+22,079
+31% +$1.73M 0.06% 342
2025
Q1 		$6.31M Sell
71,298
-411
-0.6% -$35.7K 0.05% 371
2024
Q4 		$5.51M Buy
+71,709
New +$5.01M 0.04% 404

Other funds holding WGS

Corvex Management
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Silvercrest Asset Management's WGS Position: Q2 2026 in Review

Silvercrest Asset Management sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 76,383 shares — an estimated $4.91M sold.

Silvercrest Asset Management first reported a position in WGS in Q4 2024 and held it in 6 quarters. The position peaked at $8.62M in Q2 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Silvercrest Asset Management reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
  • Silvercrest Asset Management sold 76,383 GeneDx Holdings shares in Q2 2026, an estimated $4.91M.
  • Silvercrest Asset Management first reported a position in GeneDx Holdings in Q4 2024 and held it in 6 quarters.
  • Silvercrest Asset Management's GeneDx Holdings position peaked at $8.62M in Q2 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.